IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles

Built-in SDMA delivers earlier insights with seamless workflow WESTBROOK, Maine — IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that SDMA, a renal biomarker, will be built into Catalyst™ CLIPs, making complete kidney function evaluation part of the most common point-of-care chemistry profiles. Available beginning in June to customers... The post IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles appeared first on Montreal Gazette .

Original source: Montreal Gazette